CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-21 | Ralls-Morrison Desiree SVP, GC and Corp Secretary | Shares withheld for taxes | −389 | $38.03 | $15K | 29,909 |
| 2021-02-21 | Ralls-Morrison Desiree SVP, GC and Corp Secretary | Exercise or conversion · Deferred Stock Units | −1,324 | 2,648 | ||
| 2021-02-21 | Pierce David A EVP Pres MedSurg | Exercise or conversion | +2,492 | 12,152 | ||
| 2021-02-21 | Pierce David A EVP Pres MedSurg | Shares withheld for taxes | −1,106 | $38.03 | $42K | 11,046 |
| 2021-02-21 | Pierce David A EVP Pres MedSurg | Exercise or conversion · Deferred Stock Units | −2,492 | 4,986 | ||
| 2021-02-21 | Olson Scott SVP & Pres, Rhythm Management | Exercise or conversion | +1,090 | 13,351 | ||
| 2021-02-21 | Olson Scott SVP & Pres, Rhythm Management | Shares withheld for taxes | −529 | $38.03 | $20K | 12,822 |
| 2021-02-21 | Olson Scott SVP & Pres, Rhythm Management | Exercise or conversion · Deferred Stock Units | −1,090 | 2,181 | ||
| 2021-02-21 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion | +1,713 | 243,358 | ||
| 2021-02-21 | Nanavaty Maulik SVP & Pres, Neuromodulation | Shares withheld for taxes | −593 | $38.03 | $23K | 242,765 |
| 2021-02-21 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion · Deferred Stock Units | −1,713 | 3,428 | ||
| 2021-02-21 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion | +623 | 35,895 | ||
| 2021-02-21 | Monson Jonathan VP, Global Controller and CAO | Shares withheld for taxes | −219 | $38.03 | $8K | 35,676 |
| 2021-02-21 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion · Deferred Stock Units | −623 | 1,246 | ||
| 2021-02-21 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +2,804 | 137,759 | ||
| 2021-02-21 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −969 | $38.03 | $37K | 136,790 |
| 2021-02-21 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Deferred Stock Units | −2,804 | 5,608 | ||
| 2021-02-21 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion | +1,012 | 32,132 | ||
| 2021-02-21 | Meredith Ian T EVP Global Chief Med Officer | Shares withheld for taxes | −298 | $38.03 | $11K | 31,834 |
| 2021-02-21 | Meredith Ian T EVP Global Chief Med Officer | Exercise or conversion · Deferred Stock Units | −1,012 | 2,026 |
Page 100 of 104 · 2,069 trades